Ensign Peak Advisors
HALO icon

Ensign Peak Advisors’s Halozyme HALO Stock Holding History

Ensign Peak Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Sell
6,268
-9,372
-60% -$639K ﹤0.01% 992
2026
Q1 		$1.01M Sell
15,640
-2,323
-13% -$164K ﹤0.01% 833
2025
Q4 		$1.21M Sell
17,963
-2,855
-14% -$192K ﹤0.01% 781
2025
Q3 		$1.53M Sell
20,818
-16,100
-44% -$1.07M ﹤0.01% 883
2025
Q2 		$1.92M Sell
36,918
-5,750
-13% -$327K ﹤0.01% 921
2025
Q1 		$2.72M Hold
42,668
– – 0.01% 800
2024
Q4 		$2.04M Hold
42,668
– – ﹤0.01% 932
2024
Q3 		$2.44M Hold
42,668
– – ﹤0.01% 864
2024
Q2 		$2.23M Hold
42,668
– – ﹤0.01% 863
2024
Q1 		$1.74M Sell
42,668
-295,932
-87% -$11.1M ﹤0.01% 986
2023
Q4 		$12.5M Hold
338,600
– – 0.02% 384
2023
Q3 		$12.9M Hold
338,600
– – 0.03% 333
2023
Q2 		$12.2M Buy
338,600
+293,780
+655% +$10M 0.02% 374
2023
Q1 		$1.71M Buy
44,820
+1,650
+4% +$77.4K ﹤0.01% 907
2022
Q4 		$2.46M Buy
43,170
+600
+1% +$30.7K 0.01% 748
2022
Q3 		$1.68M Hold
42,570
– – ﹤0.01% 847
2022
Q2 		$1.87M Sell
42,570
-3,564
-8% -$154K ﹤0.01% 826
2022
Q1 		$1.84M Hold
46,134
– – ﹤0.01% 922
2021
Q4 		$1.85M Sell
46,134
-156,909
-77% -$5.86M ﹤0.01% 987
2021
Q3 		$8.26M Buy
203,043
+49,732
+32% +$2.08M 0.02% 480
2021
Q2 		$6.96M Hold
153,311
– – 0.01% 531
2021
Q1 		$6.39M Buy
153,311
+11,006
+8% +$502K 0.01% 541
2020
Q4 		$6.08M Buy
142,305
+89,700
+171% +$3.22M 0.01% 547
2020
Q3 		$1.38M Buy
52,605
+43,682
+490% +$1.22M ﹤0.01% 1164
2020
Q2 		$239K Hold
8,923
– – ﹤0.01% 1564
2020
Q1 		$161K Sell
8,923
-8,924
-50% -$169K ﹤0.01% 1554
2019
Q4 		$316K Buy
+17,847
New +$309K ﹤0.01% 1585

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Ensign Peak Advisors's HALO Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Halozyme (HALO) stake by 60% in Q2 2026, selling an estimated $639K and leaving 6,268 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #992.

Ensign Peak Advisors first reported a position in HALO in Q4 2019 and has held it in 27 quarters since. The position peaked at $12.9M in Q3 2023. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Ensign Peak Advisors held 6,268 shares of Halozyme worth $491K as of Q2 2026.
  • Ensign Peak Advisors sold 9,372 Halozyme shares in Q2 2026, an estimated $639K.
  • Halozyme made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #992 holding.
  • Ensign Peak Advisors first reported a position in Halozyme in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Halozyme position peaked at $12.9M in Q3 2023.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.